168 related articles for article (PubMed ID: 19776211)
21. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
[TBL] [Abstract][Full Text] [Related]
22. Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model.
Thomaseth K; Salvan A
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):743-53. PubMed ID: 9599726
[TBL] [Abstract][Full Text] [Related]
23. Toxicological potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin relative to 100 other compounds: a relative potency analysis of in vitro and in vivo test data.
Jones TD
Arch Environ Contam Toxicol; 1995 Jul; 29(1):77-85. PubMed ID: 7794015
[TBL] [Abstract][Full Text] [Related]
24. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
25. Quantitative characterization of changes in bone geometry, mineral density and biomechanical properties in two rat strains with different Ah-receptor structures after long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Herlin M; Kalantari F; Stern N; Sand S; Larsson S; Viluksela M; Tuomisto JT; Tuomisto J; Tuukkanen J; Jämsä T; Lind PM; Håkansson H
Toxicology; 2010 Jun; 273(1-3):1-11. PubMed ID: 20403408
[TBL] [Abstract][Full Text] [Related]
26. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
27. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example.
Heinzl H; Mittlböck M; Edler L
Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175
[TBL] [Abstract][Full Text] [Related]
28. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
29. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
[TBL] [Abstract][Full Text] [Related]
30. Relative cancer potencies of selected dioxin-like compounds on a body-burden basis: comparison to current toxic equivalency factors (TEFs).
Gray MN; Aylward LL; Keenan RE
J Toxicol Environ Health A; 2006 May; 69(10):907-17. PubMed ID: 16728370
[TBL] [Abstract][Full Text] [Related]
31. Identifying soil cleanup criteria for dioxins in urban residential soils: how have 20 years of research and risk assessment experience affected the analysis?
Paustenbach DJ; Fehling K; Scott P; Harris M; Kerger BD
J Toxicol Environ Health B Crit Rev; 2006; 9(2):87-145. PubMed ID: 16613806
[TBL] [Abstract][Full Text] [Related]
32. Probabilistic risk assessment of exposure to leucomalachite green residues from fish products.
Chu YL; Chimeddulam D; Sheen LY; Wu KY
Food Chem Toxicol; 2013 Dec; 62():770-6. PubMed ID: 24140969
[TBL] [Abstract][Full Text] [Related]
33. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
34. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
[TBL] [Abstract][Full Text] [Related]
35. Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responses.
Kim AH; Kohn MC; Portier CJ; Walker NJ
Regul Toxicol Pharmacol; 2002 Dec; 36(3):287-96. PubMed ID: 12473413
[TBL] [Abstract][Full Text] [Related]
36. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
[TBL] [Abstract][Full Text] [Related]
37. Application of a biologically-based RFD estimation method to tetrachlorodibenzo-p-dioxin (TCDD) mediated immune suppression and enzyme induction.
McGrath LF; Georgopoulos P; Gallo MA
Risk Anal; 1996 Aug; 16(4):539-48. PubMed ID: 8819344
[TBL] [Abstract][Full Text] [Related]
38. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
Bogen KT
Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains.
Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
Toxicol Appl Pharmacol; 2002 May; 181(1):38-47. PubMed ID: 12030841
[TBL] [Abstract][Full Text] [Related]
40. Quantitative cancer risk assessments for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Sielken RL
Food Chem Toxicol; 1987 Mar; 25(3):257-67. PubMed ID: 3570116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
